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Discussion Surgical selective hyponeurotisation followed by a
good rehabilitation is an effective treatment for patients with
excessive localized spasticity on lower limbs. It allows a decrease
of spasticity and pain, and a functional improvement. This
technique followed by a good rehabilitation could be a good
alternative to Botulinum Toxin offering effective results with an
acceptable durability and an affordable cost.
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Fibularis lungus (FL) action and participation in gait disorders is
often underestimated, although ﬁrst description of the impact on
gait of a FL ‘‘spasm’’ dates from 1872 [1].
Case history Thirty years aged men, with multiple sclerosis
spastic tetraparesis, cerebellar hypotonia and ataxia. Functional
exam: completely independent in everyday life activities, with
difﬁculties to put on shoes, needing one croutch outside. Physical
exam: paresthesia, thermoalgesic and proprioceptive hypoesthesia
in both lower legs (LL), proximal weakness prevailing on the left,
dystonia of extensor hallucis longus (Hallucis erectus) and clonus
of soleus and gastrocnemius of both legs.
Gait analysis FL is responsible for a left-hand side pattern
prevailing on the left-hand side, associating ‘‘footdrop’’ and sole’s
eversion during swinging phase, valgus-valgus instability of the
heel during stance and heel medial-lateral oscillations when
standing tiptoe; [pre-injection video].
Treatement’s history First, all three calf muscles of both legs have
been injected (total of 300 UI Botox) but patient developed a
botulism-like syndrome with; he had no proﬁt of second injection
with 25 units in both gastrocnemius and TP of each leg, rather it
caused drastic weakening of propulsion. Treatment aims: improve
control of inversion-eversion couple during terminal stance,
without weakening propulsion strength or heel’s medio-lateral
stability during tiptoe stance.
Treatment Injection of only left leg trigger muscles (FL and it’s
antagonists: TP, Extensor Hallucis Longus) with 50 UI each
(total = 150)
Post injection exam bilateral decrease of medial-lateral heel &
leg-body oscillationsduring tiptoe stance, better leg shortenig
during swing & no personal sensation of propulsion.
Conclusion muscles actions must always be considered taking
into account both proximal and distal ﬁxed points. In case of
proximal ﬁxed point, LPL plantar ﬂexes foot and reverse sole; when
ﬁxed point is distal, FL steadies leg (and body) upon the foot in
frontal plane and draws leg’s lateral side outwards.
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Background Botulinum toxin type A (BTA) belongs to a thera-
peutic arsenal of the spastic equinus feet (SEF) in cerebral palsy
(CP) and in association with splints posture, walking orthoses and
kinesitherapy.
Aim To evaluate the results of BTA on SEF in CP using modiﬁed
Ashworth scale (MAS) and the Silfverskiold test (ST) among
children over 2 years old.
Patients and methods It’s a retrospective, descriptive study,
performed from January 2013 to January 2014 at the PMR
department of Douera’s hospital university.
We’ve included children with SEF who’ve never been treated
before.
We’ve excluded children who’ve been injected with BTA in muscle
groups other than the Triceps surae.
The protocol consisted of BTA injections, followed by the
rehabilitation program a month later.
Assessmentswere done usingMAS and ST before and after the total
injections.
Results Twenty-one children were examined (13 girls and
8 boys; mean ages of 7.5  3.58 years).
SEF was static in 19% and dynamic in 38.1% of cases. It was static
and dynamic in the remaining 42.9%.
The soleus was injected in 9.5% of cases, gastrocnemius in 19% of
cases and triceps surae in 71.4%. The average number of injections
was 2.90  1.18.
Improvement was observed in both MAS and ST comparing before
and after treatments by BTA. These results are statistically
signiﬁcant with P value of < 0.0001 (mean of Ashworth
scale2.76  0.54 vs 1.33  0.57).
Discussion-conclusion There was a decrease in triceps surae
spasticity and stabilization or improvement of tarsal ankle angle.
These measures only evaluate one aspect of SEF.
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